These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. MRI time series modeling of MS lesion development. Meier DS; Guttmann CR Neuroimage; 2006 Aug; 32(2):531-7. PubMed ID: 16806979 [TBL] [Abstract][Full Text] [Related]
31. Features of Virchow-Robin spaces in newly diagnosed multiple sclerosis patients. Etemadifar M; Hekmatnia A; Tayari N; Kazemi M; Ghazavi A; Akbari M; Maghzi AH Eur J Radiol; 2011 Nov; 80(2):e104-8. PubMed ID: 20650586 [TBL] [Abstract][Full Text] [Related]
32. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441 [TBL] [Abstract][Full Text] [Related]
33. Pilot study to examine the effect of antibiotic therapy on MRI outcomes in RRMS. Sriram S; Yao SY; Stratton C; Moses H; Narayana PA; Wolinsky JS J Neurol Sci; 2005 Jul; 234(1-2):87-91. PubMed ID: 15935383 [TBL] [Abstract][Full Text] [Related]
34. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190 [TBL] [Abstract][Full Text] [Related]
35. Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693 [TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
38. Three-dimensional observation of Virchow-Robin spaces in the basal ganglia and white matter and their relevance to idiopathic normal pressure hydrocephalus. Ishikawa M; Yamada S; Yamamoto K Fluids Barriers CNS; 2015 Jun; 12():15. PubMed ID: 26113079 [TBL] [Abstract][Full Text] [Related]